Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Emily Hsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern Califor…. Hauptthemen laut MEDLINE: Promoter Regions, Genetic, Histones, Chromatin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, Margaret Kersten Ponty Endowed Postdoctoral Fellowship Award in Oncology Research at the Norris Comprehensive Cancer Center.
Abstract (Originalsprache)
The ZFX transcriptional activator binds to CpG island promoters, with a major peak at ∼200–250 bp downstream from transcription start sites. Because ZFX binds within the transcribed region, we investigated whether it regulates transcriptional elongation. We used GRO-seq to show that loss or reduction of ZFX increased Pol2 pausing at ZFX-regulated promoters. To further investigate the mechanisms by which ZFX regulates transcription, we determined regions of the protein needed for transactivation and for recruitment to the chromatin. Interestingly, although ZFX has 13 grouped zinc fingers, deletion of the first 11 fingers produces a protein that can still bind to chromatin and activate transcription. We next used TurboID-MS to detect ZFX-interacting proteins, identifying ZNF593, as well as proteins that interact with the N-terminal transactivation domain (which included histone modifying proteins), and proteins that interact with ZFX when it is bound to the chromatin (which included TAFs and other histone modifying proteins). Our studies support a model in which ZFX enhances elongation at target promoters by recruiting H4 acetylation complexes and reducing pausing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
- Department of Cellular and Molecular Medicine, UCSD School of Medicine, La Jolla, CA 92093, USA.
ORCID-Profile: Shannon Schreiner, Peggy J Farnham
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- Margaret Kersten Ponty Endowed Postdoctoral Fellowship Award in Oncology Research at the Norris Comprehensive Cancer Center
- NIH HHS
- National Institutes of Health
Zitieren
APA
Hsu, E., Hutchison, K., Liu, Y., Nicolet, C. M., Schreiner, S., Zemke, N. R., & Farnham, P. J. (2024). Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae372
Vancouver
Hsu E, Hutchison K, Liu Y, Nicolet CM, Schreiner S, Zemke NR, et al. Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae372
BibTeX
@article{Hsu2024,
author = {Hsu, Emily and Hutchison, Katherine and Liu, Yao and Nicolet, Charles M and Schreiner, Shannon and Zemke, Nathan R and Farnham, Peggy J},
title = {Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae372}
}
EUVIMED